April 2009
Volume 50, Issue 13
Free
ARVO Annual Meeting Abstract  |   April 2009
Clinical Results of pp-Vitrectomy With Densiron 68® Heavy Internal Tamponade Used for Primary Surgery in Eyes With Complicated Rhegmatogenous Retinal Detachment and Clinically Significant PVR
Author Affiliations & Notes
  • H. Gerding
    Department of Retinology, Klinik Pallas, Olten, Switzerland
  • V. Loukopoulos
    Department of Retinology, Klinik Pallas, Olten, Switzerland
  • J. Riese
    Department of Retinology, Klinik Pallas, Olten, Switzerland
  • L. Hefner
    Department of Retinology, Klinik Pallas, Olten, Switzerland
  • C. Meier
    Department of Retinology, Klinik Pallas, Olten, Switzerland
  • Z. Liampa
    Department of Retinology, Klinik Pallas, Olten, Switzerland
  • M. Timmermann
    Department of Retinology, Klinik Pallas, Olten, Switzerland
  • Footnotes
    Commercial Relationships  H. Gerding, None; V. Loukopoulos, None; J. Riese, None; L. Hefner, None; C. Meier, None; Z. Liampa, None; M. Timmermann, None.
  • Footnotes
    Support  None.
Investigative Ophthalmology & Visual Science April 2009, Vol.50, 3172. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      H. Gerding, V. Loukopoulos, J. Riese, L. Hefner, C. Meier, Z. Liampa, M. Timmermann; Clinical Results of pp-Vitrectomy With Densiron 68® Heavy Internal Tamponade Used for Primary Surgery in Eyes With Complicated Rhegmatogenous Retinal Detachment and Clinically Significant PVR. Invest. Ophthalmol. Vis. Sci. 2009;50(13):3172.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: : To analyze long-term anatomical results, functional outcome and complications in eyes treated with Densiron tamponade during primary surgery.

Methods: : Densiron was applied in 26 eyes (26 patients, 16 male, median age 61.5, range 13-91 years). Eyes were presenting PVR stage A in 2, B in 6, C1-C3 in 17 cases, and stage D1 in 1 case. 22 of 26 eyes presented a macula-off detachment; 6 of these a partial foveal detachment. None of the eyes received additional buckling during primary surgery. Densiron was removed after a median of 62 days (range 17 to 99). 23 of 26 eyes were supplied with a mildly impressing encircling band at the time of Densiron removal. Mean follow-up was 15.1+/-12.1 months (median 11.3, range 3-43).

Results: : Complete primary retinal attachment was achieved in 26/26 eyes. 1 of 26 eyes developed PVR and secondary detachment before removal of Densiron. 3 of 26 eyes developed a redetachment centrally to the encircling band repaired by secondary intervention. At the end of the follow-up all eyes presented with attached retina; in 3 of these a limited retinal detachment anterior to cerclage was observed. LogMar visual acuity improved from a preoperative level of 1.2+/-0.96 (median 0.8) to 0.79+/-0.49 (median 0.72) at 3 months, 0.64+/-0.38 (median 0.64) at 6 months and 0.44+/-0.34 (median 0.3) at 12 months. 16 of 17 phakic eyes developed a secondary cataract (15 of 16 posterior subcapsular) during follow-up. Dispersed Densiron occurred in 10 of 26 eyes in the anterior segment, 1 case presented a gross inverse pseudohypopyon. The majority of eyes (19 of 26) needed local antiglaucomatous medication during or after the period of internal tamponde; 6 of these until the end of the follow-up period. Chronic hypotony occurred in none of the eyes.

Conclusions: : Results of this study indicate that Densiron 68® is an effective and safe heavy internal tamponade substance yielding functionally favourable results when applied in primary retinal detachment surgery with inferior retinal defects and PVR.

Keywords: retinal detachment • vitreoretinal surgery • vitreous substitutes 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×